Anjan Bera

Anjan Bera

Auto-generated profile, based on publicly available information

Anjan Bera

Department of Radiotherapy, NRS Medical College and Hospital, Kolkata, West Bengal, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2022 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
SDSharmistha Daripa
Sharmistha Daripa
SBSaptarshi Banerjee
Saptarshi Banerjee
ASAparajita Sadhya
Aparajita Sadhya
ABAnjan Bera
Anjan Bera
Objectives: The benefit of concurrent chemoradiation is often not achievable due to poor tolerance due to increased toxicity, which is a common problem in our setting, where a significant portion of carcinoma cervix patients presents at an elderly age, with medical comorbidities, and with poor performance status. In addition, many patients refuse chemotherapy. Accelerated radiation therapy remains one of the possible alternatives there. Hence, we would like to perform a prospective study to compare treatment results between Pure Accelerated Radiation versus Concomitant Chemoradiation in Locally Advanced Squamous Cell Carcinoma of Cervix. Methods: After the initial investigative work, a total of 62 histologically confirmed squamous cell carcinoma of cervix locally advanced stage (FIGO-stage IB2 to IVA.) with ECOG performance status 0–2 patients were randomized into two arms: Arm A (Study arm, n=30) – Patients received Six fractions per week of External Beam Radiotherapy without chemotherapy and Arm B (Control arm, n=32) patients received concurrent chemoradiation with Five fractions per week of radiation with Weekly Injection of Cisplatin at the dose of 40 mg/m2. Results: Overall response rates between the two arms were similar and statistically not significant (p=0.352). All acute late toxicities are similar in both arms except acute renal toxicity which is more in the control arm and the difference is statistically significant (p=0.005). Conclusions: In developing countries like India with limited treatment facilities, pure accelerated RT with brachytherapy, without concurrent chemotherapy, may be a good option and it can be viewed as an equally effective option for the elderly patients, the patients who refuse, those who have contraindications for chemotherapy, or have comorbidities. Further, multicenter, controlled, and Phase III trials will be needed to prove the benefit of the shortening overall treatment time and compare the efficacy with chemoradiation.

7 July 2022 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
CBChandrima Banerjee
Chandrima Banerjee
SBSaptarshi Banerjee
Saptarshi Banerjee
SDShatarupa Dutta
Shatarupa Dutta
ABAnjan Bera
Anjan Bera
Objectives: This study intended to explore the outcome, and toxicities of neoadjuvant chemotherapy in addition to standard treatment concomitant chemoradiation in locally advanced cervix cancer. Methods: Sixty-two (n=62) locally advanced cervical carcinoma patients were randomized into two arms: The controlled arm (30 patients) received concomitant chemoradiation with external beam radiation therapy of 50 Gy to the whole pelvis and Inj. Cisplatin (40 mg/m2/week) alone and the study arm (32 patients) received three cycles, neoadjuvant chemotherapy with Inj. Paclitaxel (175 mg/m2), and Inj. Cisplatin (75 mg/m2) at 3 weekly intervals, followed by concomitant chemoradiation with external beam radiation therapy (EBRT) of 50 Gy to whole pelvis and Inj. Cisplatin (40 mg/m2/week). Responses to treatment, toxicities, disease-free survival, and progression-free survival (PFS) were analyzed in both arms. Results: Among the total of 62 patients, 30 were in the concomitant chemoradiation alone arm and 32 were in neoadjuvant chemotherapy followed by the concomitant chemoradiation arm. The median follow-up period was about 13 months. The tumor response in the form of complete or partial responses was equivalent in the two arms. The disease-free survival and the PFS were also comparable in both arms. The acute and the late toxicities were also comparable in the two arms. Conclusions: This study showed that neoadjuvant chemotherapy with paclitaxel and cisplatin before definitive concomitant cisplatin-based chemoradiation can be used as an alternative in the management of locally advanced carcinoma of the cervix.

7 August 2022 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
ABAnjan Bera
Anjan Bera
SDShatarupa Dutta
Shatarupa Dutta
CBChandrima Banerjee
Chandrima Banerjee
SBSaptarshi Banerjee
Saptarshi Banerjee
Objectives: In areas of etiology and prevention of cancer research, Vitamin D3 is currently one of the most promising agents. By virtue of anti-inflammatory, immunomodulatory, antiangiogenic, and proapoptotic effects, Vitamin D3 may inhibit carcinogenesis, cancer cell proliferation, and tumor progression. We wanted to study the prevalence of Vitamin D3 deficiency among cancer patients and whether there is any correlation between this Vitamin D3 level with response to the treatment of cancer and survival. Methods: Between, January 2014 and December 2017, 199 patients, who completed treatment at our radiotherapy department, were included in this study. In a non-fasting state, a venous blood sample was obtained during the follow-up period, and the serum level of Vitamin D3 was determined by chemiluminescence immunoassay method. Results: A higher prevalence of suboptimal D3 concentration was seen in patients with stable or progressive disease (PD) than in those patients cured, this was statistically significant. The complete response versus partial response and PD p-values are 0.0001 and 0.0008, respectively. Overall survival (OS) difference between D3 sufficiency and insufficiency is not statistically significant (p-0.4422). However, OS difference between D3 sufficiency and deficiency is statistically significant (p-0.0001). Similarly, the OS difference between D3 insufficiency and deficiency is statistically significant (p-0.0001). Conclusions: Vitamin D3 level is significantly associated with response and there is also a positive correlation with OS. Statistically significant (p-0.0001) OS difference between D3 insufficiency and deficiency is present. Statistically significant higher prevalence of suboptimal D3 concentration was seen in patients with stable or PD than in those patients cured.

7 September 2022 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
SDShatarupa Dutta
Shatarupa Dutta
SBSaptarshi Banerjee
Saptarshi Banerjee
ABAnjan Bera
Anjan Bera
SMSrikrishna Mandal
Srikrishna Mandal
CBChandrima Banerjee
Chandrima Banerjee
Objectives: The importance and relevance of double primary are increasing with time as the increasing use of advanced diagnostic investigation and an increasing number of cancer survivors lead to an increase in double primary malignancy. Methods: We have collected data retrospectively from our own departmental patient’s record section from January 2011 to December 2021. All the details such as histopathology of both the malignancy, site of primary and secondary cancer, the time gap between the two cancer, clinical stage, and treatment received, along with demographic details have been recorded. Patients are divided into two categories either synchronous or metachronous when a second tumor develops either simultaneously or within 6 months of the diagnosis of the first tumor or 6 months after the diagnosis of the primary malignancy, respectively. Results: The total number of registered cases in one decade at our institute was 25,638 and among them were 41 double primary cases (0.16%). Twenty-two cases were metachronous (59%) and 19 cases (41%) were synchronous double primary. The most common site of double primary site was the head and neck region (38 %) followed by the lung, and esophagus (13% each), and the least common site was the colon (<1%). In the case of metachronous double primary, the mean time interval (the time gap between two cancer devolvement) was 7.4 years with a range of 2–19 years. The majority of the patients are treated with curative intention. Conclusions: The incidence of double primary is increasing over time. The management of double primary should be supervised by a multidisciplinary tumor board and more research is needed in the areas of epidemiology and treatment.

1 April 2024 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
ABAnjan Bera
Anjan Bera
AMAvik Maji
Avik Maji
DCDebasmita Chakrabarti
Debasmita Chakrabarti
SAShilpi Adhikary
Shilpi Adhikary
DMDebojyoti Manna
Debojyoti Manna
SMSrikrishna Mandal
Srikrishna Mandal
Background: The course, the origin of the branch, and the division of the aorta may vary and the aortic bifurcation level and branching can be determined by arteriogram, magnetic resonance imaging, computed tomography (CT) scan, and cadaveric dissection. Aims and Objectives: This study aimed to find the variation in aortic bifurcation levels in cervical malignancy patients who underwent radiotherapy. Materials and Methods: Between January 2018 and December 2022 previously untreated, histologically proven squamous cell carcinoma of the cervix patients who received radiotherapy in our department were selected for this retrospective analysis. A planning contrast-enhanced CT scan with a 3 mm slice thickness was done in a CT simulator to delineate the target volume and aorta, common iliac vessels in all patients. Results: 407 cervical carcinoma patients who received radiotherapy in Linear Accelerator (LINAC) were included in this analysis. The aortic bifurcation is most commonly situated at the level of the L3–L4 intervertebral disc in 290 (71.25%) cases with a range between the upper L3 body and the lower L5 body. The common iliac bifurcation was situated at the level of L5–S1 in 338 cases (83.04%) and S1 vertebral body in 63 cases (15.47%). The average length of the left common iliac artery was 4.58 cm and the right common iliac artery was 4.44 cm. The diameter of the aorta at the level of just before the bifurcation is 1.39 cm. The average diameter of the left common iliac artery and right common iliac artery were 1.21 cm and 1.13 cm, respectively. The right and left take-off angles (αR, αL) are 25.58° and 23.78°, respectively. Conclusion: The knowledge regarding the anatomic variation of branching and bifurcation of the aorta of utmost importance for surgical procedures, interventional radiology procedures, and proper radiotherapy treatment planning. Acknowledging these anatomic variations may also reduce complications.